255 related articles for article (PubMed ID: 12035294)
21. Superiority of the neonatally thymectomized Lewis rat (NTLR) to monitor a clinical trial in lepromatous leprosy of the two regimens of rifampin and dapsone.
Gelber RH; Humphres RC; Fieldsteel AH
Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):273-83. PubMed ID: 3522770
[TBL] [Abstract][Full Text] [Related]
22. Viable M. leprae as a research reagent.
Truman RW; Krahenbuhl JL
Int J Lepr Other Mycobact Dis; 2001 Mar; 69(1):1-12. PubMed ID: 11480310
[TBL] [Abstract][Full Text] [Related]
23. The mouse foot-pad technique for cultivation of Mycobacterium leprae.
Levy L; Ji B
Lepr Rev; 2006 Mar; 77(1):5-24. PubMed ID: 16715686
[TBL] [Abstract][Full Text] [Related]
24. Clinical trial of pefloxacin and ofloxacin in the treatment of lepromatous leprosy.
Grosset JH; Ji BH; Guelpa-Lauras CC; Perani EG; N'Deli LN
Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):281-95. PubMed ID: 2198315
[TBL] [Abstract][Full Text] [Related]
25. [Action of desoxyfructo-serotonin on Mycobacterium leprae. Results of inoculation of human biopsy specimens in the mouse after a year of treatment].
Ferracci C; Baquillon G; Pattyn SR
Acta Leprol; 1983; 1(4):233-5. PubMed ID: 6377799
[TBL] [Abstract][Full Text] [Related]
26. Nasal mucosa and skin of smear-positive leprosy patients after 24 months of fixed duration MDT: histopathological and microbiological study.
Ebenezer GJ; Job A; Abraham S; Arunthathi S; Rao PS; Job CK
Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):292-7. PubMed ID: 10575409
[TBL] [Abstract][Full Text] [Related]
27. Detection of Mycobacterium leprae DNA by polymerase chain reaction in the blood of individuals, eight years after completion of anti-leprosy therapy.
Santos AR; Balassiano V; Oliveira ML; Pereira MA; Santos PB; Degrave WM; Suffys PN
Mem Inst Oswaldo Cruz; 2001 Nov; 96(8):1129-33. PubMed ID: 11784934
[TBL] [Abstract][Full Text] [Related]
28. Detection of M. leprae by reverse transcription- PCR in biopsy specimens from leprosy cases: a preliminary study.
Hirawati ; Katoch K; Chauhan DS; Singh HB; Sharma VD; Singh M; Kashyap M; Katoch VM
J Commun Dis; 2006 Mar; 38(3):280-7. PubMed ID: 17373361
[TBL] [Abstract][Full Text] [Related]
29. Detection of mutations in folp1, rpoB and gyrA genes of M. leprae by PCR- direct sequencing--a rapid tool for screening drug resistance in leprosy.
Sekar B; Arunagiri K; Kumar BN; Narayanan S; Menaka K; Oommen PK
Lepr Rev; 2011 Mar; 82(1):36-45. PubMed ID: 21644470
[TBL] [Abstract][Full Text] [Related]
30. Use of NASBA RNA amplification for detection of Mycobacterium leprae in skin biopsies from untreated and treated leprosy patients.
van der Vliet GM; Cho SN; Kampirapap K; van Leeuwen J; Schukkink RA; van Gemen B; Das PK; Faber WR; Walsh GP; Klatser PR
Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4):396-403. PubMed ID: 9030105
[TBL] [Abstract][Full Text] [Related]
31. A colorimetric PCR method for the detection of M. leprae in skin biopsies from leprosy patients.
Jamil S; Wilson SM; Hacket M; Hussain R; Stoker NG
Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):512-20. PubMed ID: 7868947
[TBL] [Abstract][Full Text] [Related]
32. Mouse foot pad growth of M. leprae in relation to bacteriological index.
Bhatia VN; Balakrishnan S; Venkataramaniah HN; Harikrishnan S
Lepr India; 1983 Apr; 55(2):247-51. PubMed ID: 6355651
[TBL] [Abstract][Full Text] [Related]
33. Results of a modified WHO regimen in highly bacilliferous BL/LL patients.
Katoch K; Ramu G; Ramanathan U; Sengupta U; Sreevatsa ; Sharma VD; Shivannavar CT; Katoch VM
Int J Lepr Other Mycobact Dis; 1989 Jun; 57(2):451-7. PubMed ID: 2664042
[TBL] [Abstract][Full Text] [Related]
34. Comparative assessment of viability of M.leprae by mouse foot-pad and fluorescent staining techniques.
Sreevatsa ; Katoch VM
Indian J Lepr; 1994; 66(4):455-62. PubMed ID: 7714355
[TBL] [Abstract][Full Text] [Related]
35. Induction of lepromin positivity following immuno-chemotherapy with Mycobacterium w vaccine and multidrug therapy and its impact on bacteriological clearance in multibacillary leprosy: report on a hospital-based clinical trial with the candidate antileprosy vaccine.
Sharma P; Kar HK; Misra RS; Mukherjee A; Kaur H; Mukherjee R; Rani R
Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):259-69. PubMed ID: 10575405
[TBL] [Abstract][Full Text] [Related]
36. Effect of cryo preservation on Mycobacterium leprae growth in the footpads of non-immunosuppressed mice.
Wakade AV; Shetty VP
Lepr Rev; 2007 Dec; 78(4):381-5. PubMed ID: 18309712
[TBL] [Abstract][Full Text] [Related]
37. Mutations in genes related to drug resistance in Mycobacterium leprae isolates from leprosy patients in Korea.
You EY; Kang TJ; Kim SK; Lee SB; Chae GT
J Infect; 2005 Jan; 50(1):6-11. PubMed ID: 15603834
[TBL] [Abstract][Full Text] [Related]
38. Viability of Mycobacterium leprae in lepromatous patients after five years of dapsone monotherapy supplemented with two years of multidrug therapy.
Sivaprasad N; Snehalatha S; Lobo D; Aschhoff M; Job CK
Indian J Lepr; 1995; 67(4):427-33. PubMed ID: 8849919
[TBL] [Abstract][Full Text] [Related]
39. Newer drugs in leprosy.
Grosset JH
Int J Lepr Other Mycobact Dis; 2001 Jun; 69(2 Suppl):S14-8. PubMed ID: 11757174
[TBL] [Abstract][Full Text] [Related]
40. Immunotherapy of far-advanced lepromatous leprosy patients with low-dose convit vaccine along with multidrug therapy (Calcutta trial).
Majumder V; Mukerjee A; Hajra SK; Saha B; Saha K
Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):26-36. PubMed ID: 8627110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
